Semantic Scholar uses AI to extract papers important to this topic.
The overall efficacy and safety of anti-interleukin (IL)-13 therapies remain to be fully characterized. We conducted a meta… Expand BACKGROUND
Approximately 5% to 10% of asthmatic patients achieve incomplete symptom control on current therapies. The association… Expand AIMS
IL-13 is implicated as an important mediator of the pathology of asthma. This first clinical study with GSK679586, a novel… Expand